Can Ibuprofen Be Used in Patients with Asthma and Viral URTI?
Ibuprofen should generally be avoided in patients with asthma and viral upper respiratory tract infection unless you have confirmed the patient has no history of aspirin-exacerbated respiratory disease (AERD), no severe asthma, and no nasal polyps or chronic rhinosinusitis. 1
Understanding the Risk: Aspirin-Exacerbated Respiratory Disease
The primary concern with ibuprofen in asthma patients is aspirin-exacerbated respiratory disease (AERD), which occurs through COX-1 inhibition and shunting of arachidonic acid down the leukotriene pathway—not a true IgE-mediated allergy. 1 This means:
- High cross-reactivity exists between aspirin and all NSAIDs (including ibuprofen) because they share COX-1 inhibition 1
- The prevalence is 0.07% in the general population but rises to 21% in adults with asthma 1
- Risk is dramatically higher in patients with the triad of asthma + nasal polyps + chronic rhinosinusitis 1
FDA Contraindication
The FDA drug label explicitly states: "Ibuprofen should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients." 2
Clinical Decision Algorithm
HIGH-RISK patients (AVOID ibuprofen):
- Severe asthma with nasal polyps or chronic rhinosinusitis 1, 3
- Personal history of aspirin or NSAID-induced bronchospasm 2, 3
- Family history of aspirin-induced asthma 4
- Teenagers or adults with severe asthma and chronic rhinosinusitis 3
LOWER-RISK patients (may consider with caution):
- Young children with mild, episodic wheeze 3
- Well-controlled asthma without nasal disease 4
- No personal or family history of NSAID reactions 4
Important Caveats
The asthmatic reaction is dose-dependent and can occur even with sub-therapeutic doses. 3 This means that even if a patient has tolerated ibuprofen previously, they may still react during a viral URTI when their airways are already inflamed and hyperreactive. 5
Viral respiratory infections are the most frequent cause of acute asthma exacerbations, 5, 6 making this clinical scenario particularly high-risk for triggering bronchospasm with NSAID use.
Safer Alternatives
- Acetaminophen (paracetamol) is probably safe for fever and pain management in asthma patients, though rare cases of AERD have been reported with clinical doses in a subgroup of highly sensitive patients 3, 7
- COX-2 selective inhibitors show low cross-reactivity with AERD 1
- Opioids and tramadol are suitable analgesic alternatives for patients with known or suspected susceptibility 3
Bottom Line for Clinical Practice
Given that viral URTIs already increase asthma exacerbation risk 5, 6, and that NSAID-induced bronchospasm can be severe or fatal 2, 3, the risk-benefit calculation favors avoiding ibuprofen in this scenario unless you can definitively rule out AERD risk factors. When in doubt, use acetaminophen instead. 3, 7